Fluidigm Corporation (FLDM): Price and Financial Metrics


Fluidigm Corporation (FLDM): $2.91

0.07 (+2.46%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

FLDM POWR Grades


  • Sentiment is the dimension where FLDM ranks best; there it ranks ahead of 65.55% of US stocks.
  • The strongest trend for FLDM is in Stability, which has been heading up over the past 163 days.
  • FLDM ranks lowest in Growth; there it ranks in the 17th percentile.

FLDM Stock Summary

  • FLDM has a higher market value than 25.1% of US stocks; more precisely, its current market capitalization is $227,927,183.
  • With a year-over-year growth in debt of 10.12%, Fluidigm Corp's debt growth rate surpasses 69.29% of about US stocks.
  • In terms of volatility of its share price, FLDM is more volatile than 80.18% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to Fluidigm Corp, a group of peers worth examining would be SILK, AMST, AMSC, NURO, and BIGC.
  • Visit FLDM's SEC page to see the company's official filings. To visit the company's web site, go to www.fluidigm.com.

FLDM Valuation Summary

  • In comparison to the median Healthcare stock, FLDM's price/earnings ratio is 125.21% lower, now standing at -9.2.
  • FLDM's price/sales ratio has moved down 6.6 over the prior 128 months.
  • FLDM's price/sales ratio has moved down 6.6 over the prior 128 months.

Below are key valuation metrics over time for FLDM.

Stock Date P/S P/B P/E EV/EBIT
FLDM 2021-08-31 3.7 5.0 -9.2 -10.6
FLDM 2021-08-30 3.7 5.0 -9.2 -10.6
FLDM 2021-08-27 3.6 4.9 -9.0 -10.5
FLDM 2021-08-26 3.6 4.9 -8.9 -10.4
FLDM 2021-08-25 3.7 5.0 -9.1 -10.5
FLDM 2021-08-24 3.7 5.0 -9.0 -10.5

FLDM Growth Metrics

    Its 2 year revenue growth rate is now at 12.89%.
  • The 5 year net cashflow from operations growth rate now stands at 40.73%.
  • Its year over year revenue growth rate is now at 24.9%.
Over the past 67 months, FLDM's revenue has gone up $19,938,000.

The table below shows FLDM's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-09-30 136.924 -40.792 -67.833
2021-06-30 148.281 -35.897 -59.989
2021-03-31 143.321 -24.023 -55.861
2020-12-31 138.144 -15.417 -53.02
2020-09-30 125.976 -17.203 -47.679
2020-06-30 112.611 -17.152 -54.567

FLDM's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • FLDM has a Quality Grade of C, ranking ahead of 27.63% of graded US stocks.
  • FLDM's asset turnover comes in at 0.477 -- ranking 50th of 76 Measuring and Control Equipment stocks.
  • FTV, NVMI, and ITRI are the stocks whose asset turnover ratios are most correlated with FLDM.

The table below shows FLDM's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.477 0.587 -0.374
2021-03-31 0.464 0.599 -0.362
2020-12-31 0.453 0.603 -0.332
2020-09-30 0.434 0.595 -0.319
2020-06-30 0.407 0.566 -0.404
2020-03-31 0.414 0.555 -0.428

FLDM Price Target

For more insight on analysts targets of FLDM, see our FLDM price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $11.00 Average Broker Recommendation 1 (Strong Buy)

FLDM Stock Price Chart Interactive Chart >

Price chart for FLDM

FLDM Price/Volume Stats

Current price $2.91 52-week high $7.51
Prev. close $2.84 52-week low $2.67
Day low $2.67 Volume 2,692,165
Day high $2.94 Avg. volume 920,960
50-day MA $3.91 Dividend yield N/A
200-day MA $5.39 Market Cap 222.57M

Fluidigm Corporation (FLDM) Company Bio


Fluidigm Corporation develops, manufactures, and markets life science analytical and preparatory systems for growth markets such as single-cell biology and production genomics. The company was founded in 1999 and is based in South San Francisco, California.


FLDM Latest News Stream


Event/Time News Detail
Loading, please wait...

FLDM Latest Social Stream


Loading social stream, please wait...

View Full FLDM Social Stream

Latest FLDM News From Around the Web

Below are the latest news stories about Fluidigm Corp that investors may wish to consider to help them evaluate FLDM as an investment opportunity.

Fluidigm Announces Preliminary Revenue Exceeding Guidance for the Fourth Quarter and Full Year 2021

Fourth quarter preliminary revenue of $38.0 to $38.3 million Full year 2021 preliminary revenue of $130.3 to $130.6 million Base product and service revenue growth of approximately 13% for fourth quarter and 12% for full year as new Biomark OEM and CyTOF XT instruments contributed to revenue SOUTH SAN FRANCISCO, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM) today announced preliminary revenue for the fourth quarter and full year ended December 31, 2021, exceeding

Yahoo | January 11, 2022

Digital PCR Market Growth Factors, Demand and Trends Forecast to 2027 |Fluidigm, Bio-rad, ThermoFisher, RainDance

Digital PCR (dPCR) is a straightforward and reproducible strategy that doesn''t depend on an alignment bend for test target evaluation. It permits exact, profoundly touchy evaluation of nucleic acids. Furthermore, it is utilized for outright evaluation and examination of minority

OpenPR | December 24, 2021

Major Improvements In Fluidigm Corporation (FLDM) Stock Need To Be Considered

Fluidigm Corporation (NASDAQ:FLDM) price on Friday, December 10, rose 1.68% above its previous days close as an upside momentum from buyers pushed the stocks value to $4.24. A look at the stocks price movement, the close in the last trading session was $4.17, moving within a range at $4.095 and $4.33. The beta value (5-Year Major Improvements In Fluidigm Corporation (FLDM) Stock Need To Be Considered Read More »

Stocks Register | December 11, 2021

Fluidigm confirms Advanta Dx Assay detects Omicron variant of COVID-19

No summary available.

Seeking Alpha | December 7, 2021

Fluidigm Confirms Advanta Dx SARS-CoV-2 RT-PCR Assay on the Company’s Biomark Platform Detects Omicron Variant of COVID-19

No Published Viral Mutations to Date, Including Omicron Variant, Meaningfully Impact the Regions of the Viral Genome Targeted by the AssaySOUTH SAN FRANCISCO, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today confirmed that Omicron variant B.1.1.529, designated by the World Health Organization as a Variant of Concern, does not impact the capability of t

Yahoo | December 7, 2021

Read More 'FLDM' Stories Here

FLDM Price Returns

1-mo N/A
3-mo -42.60%
6-mo -59.01%
1-year -57.52%
3-year -67.85%
5-year -53.74%
YTD -25.77%
2021 -34.67%
2020 72.41%
2019 -59.63%
2018 46.35%
2017 -19.09%

Continue Researching FLDM

Want to see what other sources are saying about Fluidigm Corp's financials and stock price? Try the links below:

Fluidigm Corp (FLDM) Stock Price | Nasdaq
Fluidigm Corp (FLDM) Stock Quote, History and News - Yahoo Finance
Fluidigm Corp (FLDM) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7998 seconds.